Weight loss during neoadjuvant therapy for pancreatic cancer does not predict poor outcomes. Hue JJ, Markt SC, Sugumar K, Kyasaram RK, et al. Am J Surg 2021 Oct 8. pii: S0002-9610(21)00564.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Hue JJ, Markt SC, Sugumar K, Kyasaram RK, et al. Weight loss during neoadjuvant therapy for pancreatic cancer does not predict poor outcomes. Am J Surg 2021 Oct 8. pii: S0002-9610(21)00564.
PMID: 34642044